Addition of lenalidomide to first-line R-CHOP for DLBCL

The randomized phase 2 ECOG-ACRIN E1412 study found that addition of lenalidomide to first-line R-CHOP for DLBCL was

associated with improved outcomes, including in patients withABC-DLBCL.